Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
July-2022 Volume 26 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2022 Volume 26 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Immature granulocytes: Innovative biomarker for SARS‑CoV‑2 infection

  • Authors:
    • Vasiliki Epameinondas Georgakopoulou
    • Sotiria Makrodimitri
    • Maria Triantafyllou
    • Stamatia Samara
    • Pantazis M. Voutsinas
    • Amalia Anastasopoulou
    • Chrysovalantis V. Papageorgiou
    • Demetrios A. Spandidos
    • Aikaterini Gkoufa
    • Petros Papalexis
    • Euthalia Xenou
    • Georgios Chelidonis
    • Pagona Sklapani
    • Nikolaos Trakas
    • Nikolaos V. Sipsas
  • View Affiliations / Copyright

    Affiliations: Department of Infectious Diseases‑COVID‑19 Unit, Laiko General Hospital, 11527 Athens, Greece, First Department of Internal Medicine, Laiko General Hospital, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece, Pulmonology Department, Laiko General Hospital, 11527 Athens, Greece, Laboratory of Clinical Virology, Medical School, University of Crete, 71003 Heraklion, Greece, Unit of Endocrinology, First Department of Propedeutic and Internal Medicine, Laiko General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece, Laboratory of Hematology, Laiko General Hospital, 11527 Athens, Greece, National Actuarial Authority, 10559 Athens, Greece, Department of Cytology, Mitera Hospital, 15123 Athens, Greece, Department of Biochemistry, Sismanogleio Hospital, 15126 Athens, Greece
    Copyright: © Georgakopoulou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 217
    |
    Published online on: May 12, 2022
       https://doi.org/10.3892/mmr.2022.12733
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Immature granulocytes (IGs) include metamyelocytes, myelocytes and promyelocytes, and are the precursors of neutrophils. Increased IG counts found in peripheral blood indicate an enhanced bone marrow activity. In addition, IGs have been evaluated in numerous clinical conditions, such as severe acute pancreatitis, systemic inflammatory response syndrome and infectious complications following open‑heart surgery under cardiopulmonary bypass. Neutrophils are considered to play a crucial role in the host defense during bacterial and fungal infections, and are involved in the antiviral immune response. Numerous studies have reported the role of neutrophils in coronavirus disease 2019 (COVID‑19) infection, concluding that the percentage of neutrophils may be a predictor of the severity of COVID‑19 infection. There has been limited research regarding the role of neutrophil precursors in viral infections, including severe acute respiratory syndrome coronavirus 2 infection. The present thus aimed to evaluate the role of the IG count in patients hospitalized due to COVID‑19 infection. The patients were predominantly infected with the alpha variant and were all unvaccinated. The IG count was measured and was found to be associated with disease severity, with patient outcomes, with the duration of hospitalization and with the development of complications. The IG count was a significantly associated with the severity of COVID‑19 infection, with greater IG count values being detected in severe and critical cases. In addition, greater IG count values were associated with a longer duration of hospitalization. Furthermore, the IG count was found to be an independent prognostic biomarker of intubation and mortality in patients with COVID‑19, according to multivariate logistic regression analysis, including age, the male sex and the presence of comorbidities as confounders.
View Figures

Figure 1

View References

1 

Lipiński M and Rydzewska G: Immature granulocytes predict severe acute pancreatitis independently of systemic inflammatory response syndrome. Prz Gastroenterol. 12:140–144. 2017.

2 

Huang Y, Xiao J, Cai T, Yang L, Shi F, Wang Y, Li Y, Shi T, Li C, Peng Y, et al: Immature granulocytes: A novel biomarker of acute respiratory distress syndrome in patients with acute pancreatitis. J Crit Care. 50:303–308. 2019. View Article : Google Scholar : PubMed/NCBI

3 

Nierhaus A, Klatte S, Linssen J, Eismann NM, Wichmann D, Hedke J, Braune SA and Kluge S: Revisiting the white blood cell count: Immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis-a prospective, observational study. BMC Immunol. 14:82013. View Article : Google Scholar

4 

Ayres LS, Sgnaolin V and Munhoz TP: Immature granulocytes index as early marker of sepsis. Int J Lab Hematol. 41:392–396. 2019. View Article : Google Scholar

5 

Ansari-Lari MA, Kickler TS and Borowitz MJ: Immature granulocyte measurement using the Sysmex XE-2100. Relationship to infection and sepsis. Am J Clin Pathol. 120:795–799. 2003. View Article : Google Scholar

6 

Daix T, Guérin E, Tavernier E, Marsaud JP, Hacan A, Gauthier F, Piccardo A, Vignon P, Feuillard J and François B: Immature granulocytes: A risk factor of infection after cardiac surgery. Cytometry B Clin Cytom. 94:887–894. 2018. View Article : Google Scholar : PubMed/NCBI

7 

Galani IE and Andreakos E: Neutrophils in viral infections: Current concepts and caveats. J Leukoc Biol. 98:557–564. 2015. View Article : Google Scholar

8 

Naumenko V, Turk M, Jenne CN and Kim SJ: Neutrophils in viral infection. Cell Tissue Res. 371:505–516. 2018. View Article : Google Scholar : PubMed/NCBI

9 

Daher KA, Selsted ME and Lehrer RI: Direct inactivation of viruses by human granulocyte defensins. J Virol. 60:1068–1074. 1986. View Article : Google Scholar

10 

Bai F, Kong KF, Dai J, Qian F, Zhang L, Brown CR, Fikrig E and Montgomery RR: A paradoxical role for neutrophils in the pathogenesis of West Nile virus. J Infect Dis. 202:1804–1812. 2010. View Article : Google Scholar : PubMed/NCBI

11 

Faden H, Hong JJ and Ogra PL: Interaction of polymorphonuclear leukocytes and viruses in humans: Adherence of polymorphonuclear leukocytes to respiratory syncytial virus-infected cells. J Virol. 52:16–23. 1984. View Article : Google Scholar

12 

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, et al: Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 323:1061–1069. 2020. View Article : Google Scholar : PubMed/NCBI

13 

Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memish ZA, Drosten C, et al: The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 91:264–266. 2020. View Article : Google Scholar : PubMed/NCBI

14 

Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, Wang Z, Li J, Li J, Feng C, et al: Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci. 63:364–374. 2020. View Article : Google Scholar

15 

Georgakopoulou VE, Lembessis P, Skarlis C, Gkoufa A, Sipsas NV and Mavragani CP: Hematological abnormalities in COVID-19 disease association with type I interferon pathway activation and disease outcomes. Front Med (Lausanne). 9:8504722022. View Article : Google Scholar : PubMed/NCBI

16 

Chen R, Sang L, Jiang M, Yang Z, Jia N, Fu W, Xie J, Guan W, Liang W, Ni Z, et al: Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. J Allergy Clin Immunol. 146:89–100. 2020. View Article : Google Scholar

17 

National Institutes of Health, . COVID-19 treatment guidelines panel: Coronavirus disease 2019 (COVID-19) treatment guidelines. https://www.covid19treatmentguidelines.nih.gov/October 20–2021

18 

Scapini P, Marini O, Tecchio C and Cassatella MA: Human neutrophils in the saga of cellular heterogeneity: Insights and open questions. Immunol Rev. 273:48–60. 2016. View Article : Google Scholar : PubMed/NCBI

19 

Manz MG and Boettcher S: Emergency granulopoiesis. Nat Rev Immunol. 14:302–314. 2014. View Article : Google Scholar

20 

De Santo C, Salio M, Masri SH, Lee LY, Dong T, Speak AO, Porubsky S, Booth S, Veerapen N, Besra GS, et al: Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. J Clin Invest. 118:4036–4048. 2008. View Article : Google Scholar

21 

Reusch N, De Domenico E, Bonaguro L, Schulte-Schrepping J, Baßler K, Schultze JL and Aschenbrenner AC: Neutrophils in COVID-19. Front Immunol. 12:6524702021. View Article : Google Scholar

22 

Myari A, Papapetrou E and Tsaousi C: Diagnostic value of white blood cell parameters for COVID-19: Is there a role for HFLC and IG? Int J Lab Hematol. 44:104–111. 2022. View Article : Google Scholar

23 

Georgakopoulou VE, Garmpis N, Damaskos C, Valsami S, Dimitroulis D, Diamantis E, Farmaki P, Papageorgiou CV, Makrodimitri S, Gravvanis N, et al: The impact of peripheral eosinophil counts and eosinophil to lymphocyte ratio (ELR) in the clinical course of COVID-19 patients: A retrospective study. In Vivo. 35:641–648. 2021. View Article : Google Scholar : PubMed/NCBI

24 

Carissimo G, Xu W, Kwok I, Abdad MY, Chan YH, Fong SW, Puan KJ, Lee CY, Yeo NK, Amrun SN, et al: Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19. Nat Commun. 11:52432020. View Article : Google Scholar : PubMed/NCBI

25 

Nahm CH, Choi JW and Lee J: Delta neutrophil index in automated immature granulocyte counts for assessing disease severity of patients with sepsis. Ann Clin Lab Sci. 38:241–246. 2008.

26 

Kuri-Cervantes L, Pampena MB, Meng W, Rosenfeld AM, Ittner CAG, Weisman AR, Agyekum RS, Mathew D, Baxter AE, Vella LA, et al: Comprehensive mapping of immune perturbations associated with severe COVID-19. Sci Immunol. 5:eabd71142020. View Article : Google Scholar

27 

Schulte-Schrepping J, Reusch N, Paclik D, Baßler K, Schlickeiser S, Zhang B, Krämer B, Krammer T, Brumhard S, Bonaguro L, et al: Severe COVID-19 is marked by a dysregulated myeloid cell compartment. Cell. 182:1419–1440.e23. 2020. View Article : Google Scholar

28 

Combadière B, Adam L, Guillou N, Quentric P, Rosenbaum P, Dorgham K, Bonduelle O, Parizot C, Sauce D, Mayaux J, et al: LOX-1-expressing immature neutrophils identify critically-Ill COVID-19 patients at risk of thrombotic complications. Front Immunol. 12:7526122021. View Article : Google Scholar

29 

Birben B, Birben OD, Akın T, Akkurt G, Surel AA, Yakısık E and Erdem D: Efficacy of the delta neutrophil index in predicting 30-day mortality in COVID-19 patients requiring intensive care. Int J Clin Pract. 75:e139702021. View Article : Google Scholar

30 

Karagol C, Tehci AK, Gungor A, Ekici Tekin Z, Çelikel E, Aydın F, Kurt T, Sezer M, Tekgöz N, Coşkun S, et al: Delta neutrophil index and C-reactive protein: A potential diagnostic marker of multisystem inflammatory syndrome in children (MIS-C) with COVID-19. Eur J Pediatr. 181:775–781. 2022. View Article : Google Scholar : PubMed/NCBI

31 

Daix T, Jeannet R, Hernandez Padilla AC, Vignon P, Feuillard J and François B: Immature granulocytes can help the diagnosis of pulmonary bacterial infections in patients with severe COVID-19 pneumonia. J Intensive Care. 9:582021. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Georgakopoulou VE, Makrodimitri S, Triantafyllou M, Samara S, Voutsinas PM, Anastasopoulou A, Papageorgiou CV, Spandidos DA, Gkoufa A, Papalexis P, Papalexis P, et al: Immature granulocytes: Innovative biomarker for SARS‑CoV‑2 infection. Mol Med Rep 26: 217, 2022.
APA
Georgakopoulou, V.E., Makrodimitri, S., Triantafyllou, M., Samara, S., Voutsinas, P.M., Anastasopoulou, A. ... Sipsas, N.V. (2022). Immature granulocytes: Innovative biomarker for SARS‑CoV‑2 infection. Molecular Medicine Reports, 26, 217. https://doi.org/10.3892/mmr.2022.12733
MLA
Georgakopoulou, V. E., Makrodimitri, S., Triantafyllou, M., Samara, S., Voutsinas, P. M., Anastasopoulou, A., Papageorgiou, C. V., Spandidos, D. A., Gkoufa, A., Papalexis, P., Xenou, E., Chelidonis, G., Sklapani, P., Trakas, N., Sipsas, N. V."Immature granulocytes: Innovative biomarker for SARS‑CoV‑2 infection". Molecular Medicine Reports 26.1 (2022): 217.
Chicago
Georgakopoulou, V. E., Makrodimitri, S., Triantafyllou, M., Samara, S., Voutsinas, P. M., Anastasopoulou, A., Papageorgiou, C. V., Spandidos, D. A., Gkoufa, A., Papalexis, P., Xenou, E., Chelidonis, G., Sklapani, P., Trakas, N., Sipsas, N. V."Immature granulocytes: Innovative biomarker for SARS‑CoV‑2 infection". Molecular Medicine Reports 26, no. 1 (2022): 217. https://doi.org/10.3892/mmr.2022.12733
Copy and paste a formatted citation
x
Spandidos Publications style
Georgakopoulou VE, Makrodimitri S, Triantafyllou M, Samara S, Voutsinas PM, Anastasopoulou A, Papageorgiou CV, Spandidos DA, Gkoufa A, Papalexis P, Papalexis P, et al: Immature granulocytes: Innovative biomarker for SARS‑CoV‑2 infection. Mol Med Rep 26: 217, 2022.
APA
Georgakopoulou, V.E., Makrodimitri, S., Triantafyllou, M., Samara, S., Voutsinas, P.M., Anastasopoulou, A. ... Sipsas, N.V. (2022). Immature granulocytes: Innovative biomarker for SARS‑CoV‑2 infection. Molecular Medicine Reports, 26, 217. https://doi.org/10.3892/mmr.2022.12733
MLA
Georgakopoulou, V. E., Makrodimitri, S., Triantafyllou, M., Samara, S., Voutsinas, P. M., Anastasopoulou, A., Papageorgiou, C. V., Spandidos, D. A., Gkoufa, A., Papalexis, P., Xenou, E., Chelidonis, G., Sklapani, P., Trakas, N., Sipsas, N. V."Immature granulocytes: Innovative biomarker for SARS‑CoV‑2 infection". Molecular Medicine Reports 26.1 (2022): 217.
Chicago
Georgakopoulou, V. E., Makrodimitri, S., Triantafyllou, M., Samara, S., Voutsinas, P. M., Anastasopoulou, A., Papageorgiou, C. V., Spandidos, D. A., Gkoufa, A., Papalexis, P., Xenou, E., Chelidonis, G., Sklapani, P., Trakas, N., Sipsas, N. V."Immature granulocytes: Innovative biomarker for SARS‑CoV‑2 infection". Molecular Medicine Reports 26, no. 1 (2022): 217. https://doi.org/10.3892/mmr.2022.12733
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team